| Title : DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-kappaB activation - Shinjo_2015_Am.J.Physiol.Endocrinol.Metab_309_E214 |
| Author(s) : Shinjo T , Nakatsu Y , Iwashita M , Sano T , Sakoda H , Ishihara H , Kushiyama A , Fujishiro M , Fukushima T , Tsuchiya Y , Kamata H , Nishimura F , Asano T |
| Ref : American Journal of Physiology Endocrinol Metab , 309 :E214 , 2015 |
| Abstract : Shinjo_2015_Am.J.Physiol.Endocrinol.Metab_309_E214 |
| ESTHER : Shinjo_2015_Am.J.Physiol.Endocrinol.Metab_309_E214 |
| PubMedSearch : Shinjo_2015_Am.J.Physiol.Endocrinol.Metab_309_E214 |
| PubMedID: 26015438 |
Shinjo T, Nakatsu Y, Iwashita M, Sano T, Sakoda H, Ishihara H, Kushiyama A, Fujishiro M, Fukushima T, Tsuchiya Y, Kamata H, Nishimura F, Asano T (2015)
DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-kappaB activation
American Journal of Physiology Endocrinol Metab
309 :E214
Shinjo T, Nakatsu Y, Iwashita M, Sano T, Sakoda H, Ishihara H, Kushiyama A, Fujishiro M, Fukushima T, Tsuchiya Y, Kamata H, Nishimura F, Asano T (2015)
American Journal of Physiology Endocrinol Metab
309 :E214